Nephros (NEPH) Income from Non-Controlling Interests (2013 - 2022)
Nephros (NEPH) posted Income from Non-Controlling Interests of $70000.0 for Q4 2022, down 9.09% on a QoQ basis from $77000.0 in Q3 2022, and up 14.75% year-over-year from $61000.0 in Q4 2021.
Powered by 
Analysis
Nephros (NEPH) Income from Non-Controlling Interests (2013 - 2022) Analysis & Trends
Nephros has reported Income from Non-Controlling Interests for 7 years, with the latest figure at $70000.0 in Q4 2022.
- On a quarterly basis, Income from Non-Controlling Interests rose 14.75% year-over-year to $70000.0 in Q4 2022; TTM through Dec 2022 was $276000.0, a 15.0% increase from a year earlier, with the FY2025 full-year figure at $215000.0, up 283.93% from the prior year.
- Income from Non-Controlling Interests was $70000.0 for Q4 2022 at Nephros, down from $77000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $421000.0 in Q4 2019, with the low at -$93000.0 in Q4 2018.
- Average Income from Non-Controlling Interests over 5 years is $53176.5, with a median of $60000.0 recorded in 2020.
- The sharpest annual moves came in 2019 and 2020: Income from Non-Controlling Interests surged 552.69% in 2019, then tumbled 85.51% in 2020.
- Over 5 years, Income from Non-Controlling Interests stood at -$93000.0 in 2018, then soared by 552.69% to $421000.0 in 2019, then sank by 85.51% to $61000.0 in 2020, then changed by 0.0% to $61000.0 in 2021, then advanced by 14.75% to $70000.0 in 2022.
- The last three Income from Non-Controlling Interests figures came in at $70000.0 (Q4 2022), $77000.0 (Q3 2022), and $66000.0 (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 900,000.00 |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 77,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 63,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 61,000.00 |
| Sep 30, 2020 | 60,000.00 |
| Jun 30, 2020 | 60,000.00 |
| Mar 31, 2020 | 59,000.00 |
| Dec 31, 2019 | 421,000.00 |
| Sep 30, 2019 | -60,000.00 |
| Jun 30, 2019 | -61,000.00 |
| Mar 31, 2019 | -59,000.00 |
| Dec 31, 2018 | -93,000.00 |
| Sep 30, 2014 | -3.43 Mn |
| Jun 30, 2013 | 607,000.00 |
| Mar 31, 2013 | -2.76 Mn |